DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.
DRG and its group companies would like to inform you that we have updated our website privacy policy.
If you have a question for our guest, host or DRG please submit it here.
How innovation can continue to evolve and shape the pharma space
Guest: Daphne Zohar, Founder & CEO, PureTech
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Daphne Zohar, Founder and CEO of PureTech. Daphne sheds light on how their unique and innovative business model looks to solve unmet needs and problem areas across the industry, how they differ from your typical biotech and the benefit of their problem centric approach. She explores how they’re constantly innovating their internal pipeline and adapting to the needs of the market, such as using LYT-100, an existing program, to treat post-recovery complications from COVID-19. Daphne also shares her excitement at how the industry is becoming more open to new ideas and new models for developing medicines. Watch the full interview to find out more.
About our Guest
Daphne Zohar, Founder & CEO, PureTech
Daphne Zohar is the founder, CEO and board member of PureTech. She has served as the founding CEO of many of PureTech’s Founded Entities. Ms. Zohar created PureTech, assembling a team to help implement her vision, and was a key participant in fundraising, business development and establishing the underlying programs and platforms that resulted in PureTech’s substantial pipeline, comprised of 23 product candidates and one product cleared by the FDA. She has been recognized as a leader and innovator in biotechnology by EY, BioWorld, MIT Technology Review, The Boston Globe and Scientific American, and is an editorial advisor to Xconomy.
About our Host
Mike Ward, Head of Thought Leadership, DRG
Mike Ward serves as Global Head of Thought Leadership at Decision Resources Group (DRG), part of Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.